Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.
Loftus PG, Watson L, Deedigan LM, Camarillo-Retamosa E, Dwyer RM, O'Flynn L, Alagesan S, Griffin M, O'Brien T, Kerin MJ, Elliman SJ, Barkley LR.
Loftus PG, et al. Among authors: dwyer rm.
Int J Cancer. 2021 Mar 1;148(5):1245-1259. doi: 10.1002/ijc.33383. Epub 2020 Dec 2.
Int J Cancer. 2021.
PMID: 33152121
Free PMC article.